Please login to the form below

Not currently logged in
Email:
Password:

Former Roche CEO and chairman joins Arix Bioscience

Dr Franz Humer becomes a senior independent director

Arix Bioscience Dr Franz HumerHealthcare and life science company Arix Bioscience has appointed Dr Franz Humer as a senior independent director.

Most recently, Dr Humer served as chairman and chief executive at Roche, having joined the company as head of pharmaceuticals in 1995 before becoming chief operating officer in 1996.

He is currently chairman of Diageo, a consumer goods company, and a non-executive director of Chugai Pharmaceuticals, Citigroup and Kite Pharma.

Jonathan Peacock, chairman of Arix Bioscience, said: “We are delighted to welcome to the board a director of Franz's stature.

“His experience and judgement will be a tremendous asset to Arix Bioscience as we continue to support emerging and innovative companies globally.

“Franz further strengthens a very experience board of executive and non-executive directors.”

10th November 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics